Attenuating Effect of Portulaca oleracea Extract on Chronic Constriction Injury Induced Neuropathic Pain in Rats: An Evidence of Anti-oxidative and Anti-inflammatory Effects

Author(s): Fatemeh Forouzanfar, Hossein Hosseinzadeh, Mohammad B. Khorrami, Samira Asgharzade, Hassan Rakhshandeh*

Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)

Volume 18 , Issue 4 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Background: Neuropathic pain responds poorly to drug treatments. The present study investigated the therapeutic effect of Portulaca oleracea, in chronic constriction injury (CCI)-induced neuropathic pain in rats.

Objective & Methods: Neuropathic pain was performed by putting four loose ligatures around the sciatic nerve. CCI resulted in the development of heat hyperalgesia, mechanical allodynia and cold allodynia accompanied by an increase in the contents of TNF-α, IL1β, malondialdehyde, with a reduction in total thiol content.

Results: Administration of Portulaca oleracea (100 and 200 mg/kg intraperitoneal) for 14 days in CCI rats significantly alleviated pain-related behaviors, oxidative damage and inflammatory cytokines in a dose-dependent manner.

Conclusion: In conclusion, it is suggested that the antinociceptive effects of Portulaca oleracea might be due to antioxidant and anti-inflammatory properties.

Keywords: Antinociceptive effect, antispasmodic, Portulaca oleracea, neuropathic pain, hyperalgesia, flavonoids.

Drummond ES, Dawson LF, Finch PM, Bennett GJ, Drummond PD. Increased expression of cutaneous α1-adrenoceptors after chronic constriction injury in rats. J Pain 2014; 15: 188-96.
Brzezicki MA, Zakowicz PT. Mambalgins, the venom-origin peptides as a potentially novel group of analgesics: Mini review. CNS Neurol Disord Drug Targets 2018; 17: 87-97.
Evangelista M, Cilli V, De Vitis R, Militerno A, Fanfani F. Ultra-micronized palmitoylethanolamide effects on sleep-wake rhythm and neuropathic pain phenotypes in patients with carpal tunnel syndrome: An open-label, randomized controlled study. CNS Neurol Disord Drug Targets 2018; 17: 291-8.
Wong CS, Hui GK, Chung EK, Wong SH. Diagnosis and management of neuropathic pain. Pain Manage 2014; 4: 221-31.
Islam N, Abbas M, Rahman S. Neuropathic pain and lung delivery of nanoparticulate drugs: An emerging novel therapeutic strategy. CNS Neurol Disord Drug Targets 2017; 16: 303-10.
Solimini R, Rotolo MC, Pichini S, Pacifici R. Neurological disorders in medical use of cannabis: An update. CNS Neurol Disord Drug Targets 2017; 16: 527-33.
Forouzanfar F. Medicinal herbs in the treatment of neuropathic pain: A review. Iran J Basic Med Sci 2018; 21: 347-58.
Mohanapriya S, Senthilkumar P, Sivakumar S, Dineshkumar M, Subbhuraam C. Effects of copper sulfate and copper nitrate in aquatic medium on the restoration potential and accumulation of copper in stem cuttings of the terrestrial medicinal plant, Portulaca oleracea Linn. Environ Monit Assess 2006; 121: 233-44.
Rasheed A, Afifi FU, Shaedah M, Taha MO. Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan. Pak J Pharm Sci 2004; 17: 37-45.
Zhou YX, Xin HL, Rahman K, Wang SJ, Peng C, Zhang H. Portulaca oleracea L: A review of phytochemistry and pharmacological effects. BioMed Res Int 2015; 2015925631
Yue ME, Jiang TF, Shi YP. Simultaneous determination of noradrenaline and dopamine in Portulaca oleracea L. by capillary zone electrophoresis. J Sep Sci 2005; 28: 360-4.
Zhu H, Wang Y, Liu Y, Xia Y, Tang T. Analysis of flavonoids in Portulaca oleracea L. by UV–vis spectrophotometry with comparative study on different extraction technologies. Food Anal Methods 2010; 3: 90-7.
Xu X, Yu L, Chen G. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2006; 41: 493-9.
Parry O, Marks J, Okwuasaba F. The skeletal muscle relaxant action of Portulaca oleracea: Role of potassium ions. J Ethnopharmacol 1993; 40: 187-94.
Oh KB, Chang IM, Hwang KJ, Mar W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother Res 2000; 14: 329-32.
Rashed A, Afifi F, Disi A. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 2003; 88: 131-6.
Chan K, Islam M, Kamil M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol 2000; 73: 445-51.
Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
Hosseini A, Forouzanfar F, Rakhshandeh H. Hypnotic effect of Nepeta glomerulosa on pentobarbital-induced sleep in mice. Jundishapur J Nat Pharm Prod 2016; 11.
Forouzanfar F, Amin B, Ghorbani A, et al. New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells. Eur J Pain 2018; 22: 295-310.
Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968; 25: 192-205.
Sadeghnia HR, Shaterzadeh H, Forouzanfar F, Hosseinzadeh H. Neuroprotective effect of safranal, an active ingredient of Crocus sativus, in a rat model of transient cerebral ischemia. Folia Neuropathol 2017; 55: 206-13.
Gao X, Kim HK, Chung JM, Chung K. Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 2007; 131: 262-71.
Kim HK, Park SK, Zhou J-L, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004; 111: 116-24.
Park E-S, Gao X, Chung JM, Chung K. Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci Lett 2006; 391: 108-11.
Kim HK, Kim JH, Gao X, et al. Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain. Pain 2006; 122: 53-62.
Sharma S, Kulkarni SK, Chopra K. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol 2007; 21: 89-94.
Naik AK, Tandan SK, Dudhgaonkar SP, et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain 2006; 10: 573-9.
Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 2009; 56: 702-8.
Varija D, Kumar KP, Reddy KP, Reddy VK. Prolonged constriction of sciatic nerve affecting oxidative stressors & antioxidant enzymes in rat. Indian J Med Res 2009; 129(5): 587-92.
Scheid T, Dal Bosco L, Guedes RP, Pavanato MA, Belló-Klein A, Partata WA. Sciatic nerve transection modulates oxidative parameters in spinal and supraspinal regions. Neurochem Res 2013; 38(5): 935-42.
Pathak NN, Balaganur V, Lingaraju MC, et al. Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels. Neurochem Int 2014; 68: 1-9.
Liu L, Howe P, Zhou Y-F, Xu Z-Q, Hocart C, Zhang R. Fatty acids and β-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A 2000; 893: 207-13.
Rupa LM, Mohan K, Kumar NS. Portulaca oleracea inhibit vincristine induced peripheral neuropathy: Involvement of ATP-sensitive K+ channels. Int J Basic Clin Pharmacol 2017; 3: 474-8.
Martucci C, Trovato AE, Costa B, et al. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. PAIN® 2008; 137: 81-95.
Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010; 229: 26-50.
Liu T, Jiang C-Y, Fujita T, Luo S-W, Kumamoto E. Enhancement by interleukin-1β of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol Pain 2013; 9: 16.
Kawasaki Y, Zhang L, Cheng J-K, Ji R-R. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28: 5189-94.
Brenner GJ, Ji RR, Shaffer S, Woolf CJ. Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 2004; 20: 375-84.
Samad TA, Moore KA, Sapirstein A, Billet S. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471-5.
Zhang J-M, Li H, Liu B, Brull SJ. Acute topical application of tumor necrosis factor α evokes protein kinase A-dependent responses in rat sensory neurons. J Neurophysiol 2002; 88: 1387-92.
Lee AS, Lee YJ, Lee SM, et al. Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice. Evid Based Complement Alternat Med 2012; 2012
Samarghandian S, Borji A, Farkhondeh T. Attenuation of oxidative stress and inflammation by Portulaca oleracea in Streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med 2017; 22: 562-6.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [342 - 349]
Pages: 8
DOI: 10.2174/1871527318666190314110528
Price: $65

Article Metrics

PDF: 47